Abbott Laboratories 2013 Annual Report Download - page 28

Download and view the complete annual report

Please find page 28 of the 2013 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 76

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76

26
ABBOTT 2013 ANNUAL REPORT
KEY MARKET TRENDS
• Consumer reliance on trusted brands to ensure
product quality
• Broad-based improvement in healthcare systems
around the world
• Rising middle-class incomes in emerging markets
• Role of pharmacists in patients’ choice of treatments
supports higher use of branded medications
2013 BUSINESS HIGHLIGHTS
• Continued focus on 14 key emerging markets,
which grew more than six percent in 2013*
• Launched more than 200 new products, indications
or formulations
• Portfolio expansion helped drive growth in
emerging markets
• Commercial structure addresses the specific needs of
emerging and developed markets
ESTABLISHED PHARMACEUTICALS
*excluding the impact of currency exchange
CORE THERAPEUTIC AREAS
Abbott groups its trusted pharmaceutical
brands into broad therapeutic-area portfolios
Gastroenterology
Women’s Health
Cardiovascular
Pain/Central Nervous System
Respiratory Anti-Infectives